# Gain Therapeutics (GANX) — Earnings

GANX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ganx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.19 |
| EPS estimate | −$0.17 |
| EPS surprise | −13.98% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1819411/000155837025011220/ganx-20250630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.17 | −$0.19 | -13.98% | — | — |
| Q1 2025 | May 14, 2025 | −$0.18 | −$0.16 | 11.01% | $25,000.00 | — |
| Q4 2024 | Mar 27, 2025 | −$0.18 | −$0.08 | 56.45% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.21 | −$0.17 | 17.95% | $10,000.00 | — |
| Q2 2024 | Aug 8, 2024 | −$0.19 | −$0.42 | -115.61% | $400,000.00 | — |
| Q1 2024 | May 14, 2024 | −$0.31 | −$0.22 | 29.21% | $120,000.00 | — |
| Q4 2023 | Mar 26, 2024 | −$0.31 | −$0.29 | 7.05% | $250,000.00 | — |
| Q3 2023 | Nov 14, 2023 | −$0.45 | −$0.37 | 17.04% | $337,500.00 | — |
| Q2 2023 | Aug 10, 2023 | −$0.31 | −$0.62 | -101.36% | $1.0M | — |
| Q1 2023 | May 12, 2023 | −$0.39 | −$0.43 | -9.14% | $10,000.00 | $55,180.00 |
| Q4 2022 | Mar 23, 2023 | −$0.36 | −$0.39 | -6.91% | — | — |
| Q3 2022 | Nov 10, 2022 | −$0.45 | −$0.38 | 15.08% | $51,500.00 | — |
| Q2 2022 | Aug 8, 2022 | −$0.30 | −$0.43 | -42.15% | $31,667.00 | $95,102.00 |
| Q1 2022 | May 16, 2022 | −$0.35 | −$0.28 | 19.49% | $39,000.00 | $45,006.00 |
| Q4 2021 | Mar 24, 2022 | −$0.48 | −$0.27 | 44.11% | $51,600.00 | $43,000.00 |
| Q3 2021 | Nov 12, 2021 | −$0.36 | −$0.39 | -9.83% | $20,000.00 | $27,345.00 |
| Q2 2021 | Aug 11, 2021 | −$0.27 | −$0.30 | -12.95% | — | $89,173.00 |
| Q1 2021 | May 10, 2021 | −$0.32 | −$0.31 | 2.12% | — | $5,300.00 |

## Frequently Asked Questions

### When did Gain Therapeutics (GANX) last report earnings?

Gain Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did GANX beat earnings estimates?

No. Gain Therapeutics reported EPS of −$0.19 for Q2 2025 against a −$0.17 estimate — a 13.98% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).